https://sputnikglobe.com/20211206/russia-ready-to-provide-india-with-one-shot-sputnik-vaccine-for-adolescents---producer-1091285990.html
RDIF: Russia Ready to Provide India With One-Shot Sputnik Vaccine for Adolescents
RDIF: Russia Ready to Provide India With One-Shot Sputnik Vaccine for Adolescents
Sputnik International
MOSCOW, (Sputnik) - Russia is ready to supply its single-component COVID-19 vaccine Sputnik Light and the Sputnik M vaccine for adolescents to India, who has... 06.12.2021, Sputnik International
2021-12-06T12:27+0000
2021-12-06T12:27+0000
2022-07-19T10:40+0000
pandemic
russia
asia
covid-19
sputnik v vaccine
delta variant of covid-19
https://cdn1.img.sputnikglobe.com/img/07e5/03/1f/1082501697_0:72:3385:1976_1920x0_80_0_0_1836b872fa381ab1037f6005231f9f2e.jpg
"Russia and India have joined forces since the beginning of the pandemic, with this strategic partnership including production of [the] Sputnik V and Sputnik Light vaccines. A number of agreements with partners in India have helped [the] RDIF to significantly increase our production capabilities. We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives", Dmitriev said.New Delhi is already using the Russian vaccine Sputnik V, which in April 2021 became the first foreign vaccine approved for use in India.According to the RDIF, the one-shot Sputnik Light vaccine has 70% efficacy against infection from the Delta variant of coronavirus in the first three months after standalone vaccination, with this rate rising to 83% when used as a booster shot.The RDIF has also provided India's regulator with documents for the registration of Sputnik M, a vaccine for adolescents aged 12-17, registered by Russia's Health Ministry on 24 November 2021. If approved by Indian regulators, Sputnik M could become the first registered vaccine for adolescents in the country.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/07e5/03/1f/1082501697_327:0:3058:2048_1920x0_80_0_0_60bf74a09a9d2487080592a6805748c9.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
pandemic, covid-19, sputnik v vaccine, delta variant of covid-19
pandemic, covid-19, sputnik v vaccine, delta variant of covid-19
RDIF: Russia Ready to Provide India With One-Shot Sputnik Vaccine for Adolescents
12:27 GMT 06.12.2021 (Updated: 10:40 GMT 19.07.2022) MOSCOW, (Sputnik) - Russia is ready to supply its single-component COVID-19 vaccine Sputnik Light and the Sputnik M vaccine for adolescents to India, who has proved to be a valuable partner in the fight against COVID-19, Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) said on Monday.
"Russia and India have joined forces since the beginning of the pandemic, with this strategic partnership including production of [the] Sputnik V and Sputnik Light vaccines. A number of agreements with partners in India have helped [the] RDIF to significantly increase our production capabilities. We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives", Dmitriev said.
New Delhi is already using the Russian
vaccine Sputnik V, which in April 2021 became the first foreign vaccine approved for use in India.
According to the RDIF, the one-shot Sputnik Light vaccine has 70% efficacy against infection from the Delta variant of coronavirus in the first three months after standalone vaccination, with this rate rising to 83% when used as a booster shot.
The RDIF has also provided India's regulator with documents for the registration of Sputnik M,
a vaccine for adolescents aged 12-17, registered by Russia's Health Ministry on 24 November 2021. If approved by Indian regulators, Sputnik M could become the first registered vaccine for adolescents in the country.